Rare hyperthyroidism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:181399
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare hyperthyroidism (Orphanet code 181399) is a broad classification encompassing uncommon forms of hyperthyroidism — a condition in which the thyroid gland produces excessive amounts of thyroid hormones (thyroxine and triiodothyronine). Unlike the more common causes of hyperthyroidism such as Graves disease or toxic multinodular goiter, rare forms of hyperthyroidism include conditions such as familial non-autoimmune hyperthyroidism (caused by germline activating mutations in the TSH receptor gene), TSH-secreting pituitary adenomas (thyrotropinomas), struma ovarii, and other unusual etiologies. These rare causes share the common feature of thyroid hormone excess but differ significantly in their underlying mechanisms. Excessive thyroid hormone affects multiple body systems. The cardiovascular system is prominently involved, with patients experiencing tachycardia, palpitations, atrial fibrillation, and in severe cases heart failure. The nervous system is affected with tremor, anxiety, irritability, and insomnia. Metabolic effects include unintentional weight loss despite increased appetite, heat intolerance, and excessive sweating. The musculoskeletal system may be affected with proximal muscle weakness and, over time, decreased bone mineral density leading to osteoporosis. Gastrointestinal symptoms such as increased bowel frequency may also occur. In some rare genetic forms, goiter (thyroid enlargement) may be present from birth or early childhood. Treatment depends on the specific underlying cause. Antithyroid medications (such as methimazole or propylthiouracil) may be used to control hormone levels. Beta-blockers are often employed for symptomatic relief of adrenergic symptoms. Definitive treatments may include radioactive iodine ablation or thyroidectomy. For TSH-secreting pituitary adenomas, transsphenoidal surgery is the primary treatment. In familial non-autoimmune hyperthyroidism, thyroidectomy is often preferred since antithyroid drugs may not provide lasting remission. Accurate diagnosis of the rare underlying etiology is essential to guide appropriate management.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare hyperthyroidism.

View clinical trials →

No actively recruiting trials found for Rare hyperthyroidism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare hyperthyroidism community →

No specialists are currently listed for Rare hyperthyroidism.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare hyperthyroidism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare hyperthyroidismForum →

No community posts yet. Be the first to share your experience with Rare hyperthyroidism.

Start the conversation →

Latest news about Rare hyperthyroidism

No recent news articles for Rare hyperthyroidism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare hyperthyroidism

What is Rare hyperthyroidism?

Rare hyperthyroidism (Orphanet code 181399) is a broad classification encompassing uncommon forms of hyperthyroidism — a condition in which the thyroid gland produces excessive amounts of thyroid hormones (thyroxine and triiodothyronine). Unlike the more common causes of hyperthyroidism such as Graves disease or toxic multinodular goiter, rare forms of hyperthyroidism include conditions such as familial non-autoimmune hyperthyroidism (caused by germline activating mutations in the TSH receptor gene), TSH-secreting pituitary adenomas (thyrotropinomas), struma ovarii, and other unusual etiologie